Berry Only Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
DelMar Pharmaceuticals Inc Announces Management Change-Form 8-K
DelMar Pharmaceuticals Inc reported in its Form 8-K that effective on the Closing Date (except with respect to Scott Praill, who was appointed on January 29, 2013), Lisa Guise resigned as the sole officer of the Company. Jeffrey Bacha was appointed as Chief Executive Officer (CEO) and President; Scott Praill was appointed as Chief Financial Officer (CFO).
Latest Developments for DelMar Pharmaceuticals Inc
- Share this
- Digg this